In particular, it was demonstrated that PLCβ1 gene expression was inversely correlated with the pathological grade of gliomas and that patients with intermediate PLCβ1 expression had a higher chance of survival than the PLCβ1-downregulated group [38]. The gene discussed is PLCB1; the disease is glioma.